Brendan Connell
- Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators
2026/01/08 by Ferran Fece de la Cruz, Andreas Varkaris, Parasvi S. Patel +26 · 1 voice
Medicine · Biochemistry, Genetics and Molecular Biology · #Cancer-related Molecular Pathways #Protein Degradation and Inhibitors #Microtubule and mitosis dynamics